Ascend Advanced Therapies
Philadelphia, PA
Program data pending ClinicalTrials.gov matching
· Last scored 2026-04-06
78.1
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
○ Press
✓ EMA GMP (1)
○ MHRA GMP
Quick Facts: Ascend Advanced Therapies
- Signal Score
- 78.1/100 (as of 2026-04-06)
- Quality Compliance
- 100.0/100 — No FDA inspection records found for this manufacturer
- Headquarters
- Philadelphia, PA
- Modalities
- AAV, Lentiviral, Plasmid
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
Signal Score & Pillar Breakdown
Quality Compliance
100.0
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Source: FDA Data Dashboard
No FDA inspection records found for this manufacturer · Quality score requires FDA inspection data
FDA InspectionsNo US records on file
EMA GMP Certificates1 on record
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesAAV, Lentiviral, Plasmid
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
58.0
1 manufacturing site: Philadelphia, PA
Modalities: AAV, Lentiviral, Plasmid
Capacity assessment: 58.0/100
Sites: Philadelphia, PA
Source: SEC EDGAR, press monitoring, company profiles
1 manufacturing site
1 manufacturing site: Philadelphia, PA
Modalities: AAV, Lentiviral, Plasmid
Capacity assessment: 58.0/100
EMA GMP Compliance 1 certificates
2024-09
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| DE_BY_04_GMP_2025_0088 | Ascend Advanced Therapies GmbH | Germany | 2024-09-19 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Apr 09, 2026
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Center for Breakthrough Medicines
King of Prussia, PA
Signal Score: 59.0
AAV, Lentiviral, Plasmid
Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 92.2
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral
ReciBioPharm
Keele, UK · Sodertalje, SE
Signal Score: 88.0
AAV, Lentiviral, Plasmid, mRNA
Pharmaron Biologics
San Diego, CA · Shaoxing, CN
Signal Score: 85.6
AAV, Lentiviral, Plasmid
Yposkesi (SK Pharmteco)
Corbeil-Essonnes, FR
Signal Score: 80.3
AAV, Lentiviral, Plasmid